MedTrace Logo

Zoster Vaccine Response in the Frail Elderly

NCT01328548 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 241

Last updated 2018-10-29

Study results available
· View outcomes & findings →

Summary

This study is being done to evaluate the zoster vaccine response in the nursing home elderly (80 years or older). As the immune system ages, the response to vaccines is not always as strong as in younger people. Previous zoster vaccine studies have excluded nursing home residents so the vaccine effect in this population is not known. Furthermore, the immune and genetic reasons as to why the vaccine works well in some people but not in others are also unknown. The goal of this study is to evaluate why some immune systems respond well to the vaccine and why others do not.

Conditions

  • Immune System Diseases

Interventions

DRUG

Zostavax

Sponsors & Collaborators

Principal Investigators

  • Mark B. Loeb, FRCPC,MD,MSc · McMaster University

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01328548 on ClinicalTrials.gov